MDPI and ACS Style
De Zutter, A.; Crijns, H.; Berghmans, N.; García-Caballero, M.; Vanbrabant, L.; Pörtner, N.; Vanheule, V.; Verscheure, P.; Siddiquei, M.M.; Abu El-Asrar, A.M.;
et al. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers 2021, 13, 5090.
https://doi.org/10.3390/cancers13205090
AMA Style
De Zutter A, Crijns H, Berghmans N, García-Caballero M, Vanbrabant L, Pörtner N, Vanheule V, Verscheure P, Siddiquei MM, Abu El-Asrar AM,
et al. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers. 2021; 13(20):5090.
https://doi.org/10.3390/cancers13205090
Chicago/Turabian Style
De Zutter, Alexandra, Helena Crijns, Nele Berghmans, Melissa García-Caballero, Lotte Vanbrabant, Noëmie Pörtner, Vincent Vanheule, Paulien Verscheure, Mohammad Mairaj Siddiquei, Ahmed M. Abu El-Asrar,
and et al. 2021. "The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors" Cancers 13, no. 20: 5090.
https://doi.org/10.3390/cancers13205090